Europe Molecular Weight Marker Market

Europe Molecular Weight Marker Market Analysis Report (2022 to 2027)

The size of the Molecular weight Marker market in Europe is estimated to be USD 97.55 million in 2022 and is forecasted to grow USD 173.69 million by 2027, registering at a CAGR of 12.23% from 2022 to 2027.

The molecular weight marker is used to identify protein, DNA or RNA based upon their molecular weights. The technique works based upon on agarose gel or polyacrylamide gel, where the marker migrates according to molecular weights. Key factors such as increased expenditure on R&D activities related to genomic research, growth in the use of weight markers molecular technology in separation and analysis of various molecules and increasing number of biotechnology patents are responsible for driving the market. Leeds University has invested £ 18 million in structural biology research, which would also involve the use of molecular markers in more than 50% of research activities. Such huge investments in research, with the increasing emphasis on molecular biology, are anticipated to drive the growth of the Europe molecular weight marker market during the forecast period.

Furthermore, technological advancements in molecular biology products, such as PCR and genome sequencing, along with a high-quality molecular weight markers is another key factor boosting the market growth in this region. The R&D growth rate of EU companies has increased at 5.7% during 2020, with health facilities showing 5% growth rate. The UK pharmaceutical sector is estimated to grow by 19.5% to reach a market value of £ 26 billion, which equates to an annual growth of 4.6%. Hence, it is expected that the molecular weight marker products demand will increase in the near future. Gel electrophoresis is one of the most common uses of molecular weight size markers. The purpose of gel electrophoresis is to separate proteins by their physical or chemical properties, including charge, molecular size, and pH. The SDS-PAGE or polyacrylamide gel electrophoresis and molecular weight size markers are ideal standards for sorting. These applications in pharmaceutical, biopharmaceutical industry and healthcare sector will boost the Europe molecular weight markers market during the forecast period.

However, factors such as the lack of skilled professionals in the region, high degree of consolidation restricting entry of new companies, complex regulatory standards are limiting the growth of the Europe molecular weight markers market during the forecast period.

This research report on the Europe molecular weight marker market has been segmented into the following categories:

By Product:

• DNA
• RNA
• Protein

By Type:

• Pre-stained
• Specialty

By Application: 

• PCR
• Western Blotting
• Gel Extraction
• Others

By End-User:

• Contact Research Organizations (CRO)
• Pharmaceutical Companies
• Academic Institutes

By Country: 

• United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Rest of Europe

Geographically, countries like Germany, France, Sweden and the United Kingdom hold a significant share of the European molecular weight markers market. Germany is projected to lead the studied market in terms of share during the forecast period. This is attributed to the presence of a large number of research laboratories in the region, high number of pharmaceutical companies, high healthcare expenditure and a well-developed research infrastructure. Germany is the main European pharmaceutical market and the fourth in the world. In 2019, sales of the pharmaceutical industry in Germany increased by 5.8%, reaching 46.8 billion euros. In 2019, healthcare spending in Germany exceeded € 400 billion (2019). The market has grown by 4.2% over the past 10 years.

The United Kingdom accounts for the second largest contribution to the Europe molecular weight markers market revenue share, followed by France. The French regional market is expected to grow relatively faster in terms of revenue over the next 10 years. The market growth in the UK can be attributed to the increasing focus of CROs and biotech companies in this region for drug discovery and development, development of healthcare infrastructure, availability of qualified professionals, and the increased concentration and investment of pharmaceutical and biopharmaceutical companies in R&D activities. The growing number of mergers and acquisitions between biotech and pharmaceutical companies is a key trend, which will provide growth opportunities in the years to come.

KEY MARKET PLAYERS:

Companies playing a promising role in the European molecular weight marker market profiled in this report are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Sigma-Aldrich, Affymetrix, Inc., QIAGEN, Takara Bio Inc., Bio-Rad Laboratories, Promega Corporation, and New England Biolabs.